Such statements relate to future events that by their nature address matters that are, to different degrees, uncertain.For additional information and updates to estimated liabilities as of March 31, 2018, see Part I, Item 1, Financial Statements, Note 3 (Commitments, Contingencies and Guarantees) of the Notes to Unaudited Consolidated Financial Statements included under Item 1 of this quarterly report, which is incorporated herein by reference. Net sales of this segment increased by $14 million, or 39%, in the three months ended March 31, 2018, when compared to the same period in 2017, driven by an increase in sales in our emerging businesses.
 Net sales in the three months ended March 31, 2018 were $2,500 million, compared to $2,375 million in the same period in 2017.
As a percentage of sales, these expenses increased slightly in the first quarter, when compared to the same period last year.
 In the second quarter, Optical Communications sales are expected to increase by a low-teens percentage on a year-over-year basis.
 Net sales in the Optical Communications segment increased by $68 million, or 8%, in the first quarter of 2018, due to higher sales of carrier and enterprise network products, up $49 million and $19 million, respectively.
The increase was driven by higher sales in the Optical Communications, Environmental Technologies and Life Sciences segments, up $68 million, $47 million and $22 million, respectively.
 Capital spending totaled $655 million and $364 million in the three months ended March 31, 2018 and 2017, respectively.
 Net income in the first quarter of 2018 increased by $3 million, or 13%, driven by the increase in sales described above.
 Net income in the first quarter of 2018 increased by $8 million, or 18%, driven by the sales increase outlined above and improved manufacturing efficiencies.
 Net sales in the Display Technologies segment decreased by $37 million, or 5%, in the first quarter of 2018, when compared to the first quarter of 2017.
 Net sales in the Environmental Technologies segment increased $47 million, or 17%, in the first quarter of 2018 when compared to the same period in 2017.
The company does not undertake to update forward-looking statements.
 Net sales in the Life Sciences segment increased by $22 million, or 10%, in the first quarter of 2018 when compared to the same period in 2017, driven by higher sales in North America and China.
 Net cash used in investing activities increased by $318 million in the three months ended March 31, 2018 when compared to the same period last year, driven by an increase of $291 million in capital expenditures largely due to capacity expansion projects in our Display Technologies and Optical Communications segments.
 In the three months ended March 31, 2018, we generated core earnings of $299 million or $0.31 per share, compared to core earnings generated in the three months ended March 31, 2017 of $376 million, or $0.36 per share.
We anticipate mid-single digit growth in the Life Sciences segment. Â© 2018 Corning Incorporated.